Insider Transactions in Q3 2021 at Palisade Bio, Inc. (PALI)
Insider Transaction List (Q3 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 21
2021
|
Thomas Hallam Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
6,000
+44.14%
|
$12,000
$2.49 P/Share
|
|
Sep 21
2021
|
John David Finley CEO, CFO, Director |
BUY
Open market or private purchase
|
Direct |
2,000
+12.2%
|
$4,000
$2.44 P/Share
|
|
Sep 10
2021
|
Robert J. Trenschel Director |
BUY
Open market or private purchase
|
Direct |
2,142
+12.5%
|
$4,284
$2.98 P/Share
|
|
Sep 09
2021
|
Robert J. Trenschel Director |
BUY
Open market or private purchase
|
Direct |
3,400
+20.91%
|
$6,800
$2.89 P/Share
|
|
Sep 08
2021
|
Robert J. Trenschel Director |
BUY
Open market or private purchase
|
Direct |
5,000
+34.59%
|
$10,000
$2.75 P/Share
|
|
Sep 07
2021
|
Robert J. Trenschel Director |
BUY
Open market or private purchase
|
Direct |
2,707
+37.79%
|
$5,414
$2.78 P/Share
|
|
Aug 31
2021
|
Robert J. Trenschel Director |
BUY
Open market or private purchase
|
Direct |
1,750
+50.0%
|
$3,500
$2.75 P/Share
|
|
Aug 27
2021
|
John David Finley CEO, CFO, Director |
BUY
Open market or private purchase
|
Direct |
10,000
+34.49%
|
$20,000
$2.64 P/Share
|